Falcon Vision
Menlo Park, Californiakkr.com
Overview
Falcon Vision is an ophthalmology-focused investment platform created and supported by KKR. The platform sources, evaluates, and provides operational and financial capabilities to a diversified portfolio of emerging ophthalmic medical device and biopharmaceutical companies. It collaborates with the team at Flying L Partners, led by industry veteran Dr. Bill Link, to identify and manage investment opportunities. The strategy is to address the need for capital and operational guidance to advance innovative products for under-managed ophthalmic diseases and vision preservation.
Portfolio Companies
6
Website
kkr.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ViaLase | Apr 2024 | Series C | Lead |
| Newton | Sep 2022 | Series C | Co-investor |
| Aurion Biotech | Apr 2022 | Series C | Co-investor |
| ViaLase | Nov 2021 | Series B | Lead |
| TearClear | Aug 2020 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.